REMUNITY PUMP FOR REMODULIN (TREPROSTINIL) INJECTION Trademark

Trademark Overview

On Tuesday, March 19, 2019, a trademark application was filed for REMUNITY PUMP FOR REMODULIN (TREPROSTINIL) INJECTION with the United States Patent and Trademark Office. The USPTO has given the REMUNITY PUMP FOR REMODULIN (TREPROSTINIL) INJECTION trademark a serial number of 88345768. The federal status of this trademark filing is REGISTERED as of Tuesday, May 4, 2021. This trademark is owned by United Therapeutics Corporation. The REMUNITY PUMP FOR REMODULIN (TREPROSTINIL) INJECTION trademark is filed in the Medical Instrument Products category with the following description:

Drug delivery systems

General Information

Serial Number88345768
Word MarkREMUNITY PUMP FOR REMODULIN (TREPROSTINIL) INJECTION
Filing DateTuesday, March 19, 2019
Status700 - REGISTERED
Status DateTuesday, May 4, 2021
Registration Number6342172
Registration DateTuesday, May 4, 2021
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 23, 2019

Trademark Statements

NOT AVAILABLE"PUMP" AND "(TREPROSTINIL) INJECTION"
Indication of Colors claimedThe color(s) red, dark blue, and light blue is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the words "REMUNITY PUMP" in dark blue to light blue gradient from left to right; below the wording "REMUNITY PUMP" appears the wording "FOR" in dark blue; the wording "REMODULIN" appears in red to the right of "FOR" and below appears the wording "(TREPROSTINIL) INJECTION" in red; to the left of the wording are three overlapping open circles in red, light blue, and dark blue.
Goods and ServicesDrug delivery systems

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, April 5, 2019
Primary Code010
First Use Anywhere DateThursday, June 4, 2020
First Use In Commerce DateThursday, June 4, 2020

Trademark Owner History

Party NameUnited Therapeutics Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910
US
Party NameUnited Therapeutics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910
US
Party NameUnited Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910
US

Trademark Events

Event DateEvent Description
Friday, March 22, 2019NEW APPLICATION ENTERED
Friday, April 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 6, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 30, 2019ASSIGNED TO EXAMINER
Monday, June 3, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, June 3, 2019EXAMINERS AMENDMENT E-MAILED
Monday, June 3, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 3, 2019EXAMINER'S AMENDMENT ENTERED
Monday, June 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 17, 2019ASSIGNED TO LIE
Wednesday, July 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 23, 2019PUBLISHED FOR OPPOSITION
Tuesday, July 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 11, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, March 11, 2020SOU EXTENSION 1 FILED
Wednesday, March 11, 2020SOU EXTENSION 1 GRANTED
Friday, March 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 3, 2020TEAS STATEMENT OF USE RECEIVED
Thursday, September 3, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, September 15, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 3, 2020SOU EXTENSION 2 FILED
Friday, September 18, 2020SOU EXTENSION 2 GRANTED
Thursday, September 3, 2020USE AMENDMENT FILED
Friday, September 18, 2020STATEMENT OF USE PROCESSING COMPLETE
Saturday, September 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 7, 2020SU - NON-FINAL ACTION - WRITTEN
Wednesday, October 7, 2020NON-FINAL ACTION E-MAILED
Wednesday, October 7, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 19, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 26, 2021ASSIGNED TO LIE
Friday, March 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 26, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 29, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 30, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 4, 2021REGISTERED-PRINCIPAL REGISTER
Monday, May 4, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

injection treprostinil remodulin pump remunity systems delivery drug